BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Biotech Bay

  Inside 23andMe Founder Anne Wojcicki’s $99 DNA Revolution

  October 17, 2016

   · 

  1 min read
• 

  Policy

  The History Between a Biogen Drug and a High-Profile Democratic Party Fundraiser

  October 17, 2016

   · 

  2 min read
• 

  FDA

  PTC Therapeutics Tanks After the FDA Denies DMD Drug Translarna Again

  October 17, 2016

   · 

  3 min read
• 

  Policy

  Newest WikiLeaks Dump of Clinton Emails Exposes Some Biopharma Chatter

  October 17, 2016

   · 

  4 min read
• 

  Policy

  How One Tweet From Bernie Sanders Sent Ariad’s Stock Plunging

  October 17, 2016

   · 

  3 min read
• 

  Biotech Beach

  Top 5 Best U.S. Cities for Pharma and Biotech Scientist Jobs

  October 17, 2016

   · 

  7 min read
• FDA

  Teleflex Inc. Snags FDA Green Light for the Arrow Midline with Chlorag+ard Technology

  October 17, 2016

   · 

  3 min read
• FDA

  Nuvo Pharma Receives Approval From German Regulatory Authorities To Conduct Pennsaid 2% Phase 3 Trial For Treatment Of Acute Ankle Sprains

  October 17, 2016

   · 

  5 min read
• Drug Development

  Envisia Therapeutics Releases ENV515 (Travoprost XR) Phase 2 Data Showing Nine-Month Duration Of Action After A Single Dose In Patients With Glaucoma

  October 17, 2016

   · 

  3 min read
• Drug Development

  Zynerba Provides Clinical Update For Lead Development Candidates – ZYN001 And ZYN002

  October 17, 2016

   · 

  5 min read